Researchers Develop Implantable Materials With Engineered Bacteria for Drug Delivery

Researchers have developed implantable “living materials” that use contained engineered bacteria to deliver therapeutics autonomously. The materials were described in a Science perspective article that highlights progress in overcoming a major hurdle for microbial medicine.

Microbes have long been studied as potential drug-delivery vehicles because they can be engineered to produce specific compounds inside the body. Containment has remained a central technical challenge, as uncontrolled bacterial growth or escape could pose safety risks.

The new implants keep the engineered bacteria inside a protective matrix while still allowing them to sense conditions and release therapeutic molecules. According to the report, the system operates without external control after implantation. The perspective notes that this autonomous function distinguishes the approach from earlier methods that required repeated dosing or external triggers.